A more powerful way to develop therapeutics?

July 21, 2016, University of Toronto

A University of Toronto scientist has developed a new method for identifying the raw ingredients necessary to build 'biologics', a powerful class of medications that has revolutionized treatment of diseases like rheumatoid arthritis and some cancers.

Biologics are a type of drug that results from the high-tech manipulation of our own proteins, as opposed to more traditional drugs built from synthetic chemicals. Because of their success so far, scientists are racing to create new biologics - and now, a University of Toronto researcher has developed a way to make that process more powerful.

Philip M. Kim, an associate professor in U of T's Donnelly Centre for Cellular and Biomolecular Research, combined high-tech computer simulation and high-throughput laboratory experiments to create what he hopes will be the most effective way to discover the proteins that are key to new biologics. His research was published online in the journal Science Advances on July 20, 2016.

"A large fraction of new therapeutics these days involve engineered proteins that latch onto a , for instance on a cancer cell," says Kim, also of the departments of Molecular Genetics and Computer Science. "Finding a protein that effectively binds to a target can feel like looking for a needle in a haystack. Our method should open up new opportunities to find those key proteins - and make a major impact on the development of new biologics."

Under the traditional approach to developing a biologic, researchers identify a protein of interest and then test billions of variants, either randomly generated or from a natural source, hoping to find an effective binder. But these methods allow very little control over where and how the performs this crucial function on its target - a major factor in its effectiveness.

Kim and his team took a different approach. They used a computer to simulate the binding process, and then designed proteins that would work on the target. This type of theoretical approach has been in development for several decades, but is still not effective enough. So Kim combined the best of both methods. Instead of randomly creating massive libraries of variants, as with the traditional approach, he used computer modelling to generate a smaller, but intelligently designed repertoire of variants. Designing each variant allows for the tight control of all its properties, in contrast to conventional approaches.

"We showed that this method gives you binders that are somewhat stronger than what you get with the conventional approach," says Kim. "The much smaller library also solves many technical problems, and we can screen for new, previously unscreenable, targets. It's a very exciting time for cancer research, and for biologics."

For Kim, the next step is to produce proteins that are important to certain types of cancer, but have not been screened before due to the difficulty producing them.

Explore further: Researchers map molecular 'social networks' that drive breast cancer cells

More information: M. G. F. Sun et al, Protein engineering by highly parallel screening of computationally designed variants, Science Advances (2016). DOI: 10.1126/sciadv.1600692

Related Stories

Researchers map molecular 'social networks' that drive breast cancer cells

July 14, 2016
A powerful new technology that maps the "social network" of proteins in breast cancer cells is providing detailed understanding of the disease at a molecular level and could eventually lead to new treatments, Australian scientists ...

Study visualizes proteins involved in cancer cell metabolism

May 26, 2016
Scientists using a technology called cryo-EM (cryo-electron microscopy) have broken through a technological barrier in visualizing proteins with an approach that may have an impact on drug discovery and development. They ...

Permeon reveals discovery of Intraphilins as new approach to intracellular biologic drugs

July 28, 2011
Permeon Biologics, a biopharmaceutical company pioneering a novel class of intracellular protein biologics, today announced the discovery of an entirely new class of naturally occurring human supercharged proteins called ...

Researchers identify SH2 domains as lipid-binding modules for cell signaling

March 28, 2016
Majority of human Src homology 2 domains not only bind to proteins, but also interact with membrane lipids with high affinity and specificity. The SH2 domain-containing proteins play important roles in various physiological ...

Tackling a large challenge for new modes of drug delivery

November 12, 2013
New treatments for prostate cancer, multiple sclerosis and cystic fibrosis could be developed following research being carried out into how medicinal 'biologics' can be delivered to diseased cells.

Biologics for asthma: Attacking the source of the disease, not the symptoms

November 5, 2015
Imagine you suffer from severe asthma, and you've tried every treatment available, but nothing has worked. You still can't breathe. Then a new therapy comes along that attacks the source of the asthma, as opposed to the symptoms, ...

Recommended for you

Research shows it's possible to reverse damage caused by aging cells

August 15, 2018
What's the secret to aging well? University of Minnesota Medical School researchers have answered it- on a cellular level.

This matrix delivers healing stem cells to injured elderly muscles

August 15, 2018
A car accident leaves an aging patient with severe muscle injuries that won't heal. Treatment with muscle stem cells from a donor might restore damaged tissue, but doctors are unable to deliver them effectively. A new method ...

Male tobacco smokers have brain-wide reduction of CB1 receptors

August 15, 2018
Chronic, frequent tobacco smokers have a decreased number of cannabinoid CB1 receptors, the "pot receptor", when compared with non-smokers, reports a study in Biological Psychiatry.

Byproducts of 'junk DNA' implicated in cancer spread

August 14, 2018
The more scientists explore so-called "junk" DNA, the less the label seems to fit.

Doctors may be able to enlist a mysterious enzyme to stop internal bleeding

August 14, 2018
Blood platelets are like the sand bags of the body. Got a cut? Platelets pile in to clog the hole and stop the bleeding.

Using DeepMind's neural network learning system to diagnose eye diseases

August 14, 2018
Three institutions working together have applied DeepMind's neural network learning system to the task of discovering and diagnosing eye diseases. Moorfields Eye Hospital has been working with Google's DeepMind Health subsidiary ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.